Nanobiotix Files March 2025 6-K Report
Ticker: NBTX · Form: 6-K · Filed: Mar 17, 2025 · CIK: 1760854
Sentiment: neutral
Topics: sec-filing, 6-k, regulatory-update
TL;DR
Nanobiotix filed its March 6-K, confirming 20-F annual report filing.
AI Summary
Nanobiotix S.A. filed a Form 6-K on March 17, 2025, to report its activities for the month of March 2025. The company, based in Paris, France, is a pharmaceutical preparations company and is filing its report under the Securities Exchange Act of 1934. This filing indicates they will file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates on Nanobiotix's corporate activities and confirms their reporting status with the SEC, which is important for investors tracking the company's compliance and disclosures.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- 001-39777 (company) — SEC File Number
- 20-F (company) — Annual Report Form
- 60 Rue de Wattignies (company) — Principal Executive Office Address
- Paris, France (company) — Location
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of March 2025.
What is Nanobiotix S.A.'s SEC file number?
Nanobiotix S.A.'s SEC file number is 001-39777.
Does Nanobiotix S.A. file annual reports under Form 20-F or Form 40-F?
Nanobiotix S.A. indicates by check mark that it files or will file annual reports under cover of Form 20-F.
Where is Nanobiotix S.A. located?
Nanobiotix S.A.'s principal executive office is located at 60 Rue de Wattignies, 75012 Paris, France.
What is the SIC code for Nanobiotix S.A.?
The Standard Industrial Classification (SIC) code for Nanobiotix S.A. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 17, 2025 regarding Nanobiotix S.A. (NBTX).